TP53 and B-cell chronic lymphocytic leukemia: In a recent study of newly diagnosed CLL patients, Brieghel et al. [19] found that the presence of TP53 mutations with a variant allele frequency of > 10% in the absence of TP53 deletion had no impact on overall survival or treatment-free survival.